Team
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Ophthalmology
Metabolic Disease
Neurology
Platform
Manufacturing
Product Design
Research & Development
Manufacturing
Product Design
Research & Development
Newsroom
Careers
Newsroom
Search
Search
September 12, 2024
Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene Therapy Product Candidate for Thyroid Eye Disease (TED), at ESOPRS Annual Meeting
: Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene Therapy Product Candidate for Thyroid Eye Disease (TED), at ESOPRS Annual Meeting
July 8, 2024
Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as Chief Gene Therapy Officer
: Kriya Appoints Scientific Co-Founder J. Fraser Wright, Ph.D., as Chief Gene Therapy Officer
June 18, 2024
Kriya Appoints Katherine Eade as Chief Legal Officer
: Kriya Appoints Katherine Eade as Chief Legal Officer
May 2, 2024
Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
: Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
April 23, 2024
Kriya Announces Six Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
: Kriya Announces Six Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
January 8, 2024
Kriya Provides Update on Pipeline Progress Ahead of Company Presentation at 42nd Annual J.P. Morgan Healthcare Conference
: Kriya Provides Update on Pipeline Progress Ahead of Company Presentation at 42nd Annual J.P. Morgan Healthcare Conference
January 5, 2024
Kriya Announces Gene Therapy Program for Thyroid Eye Disease
: Kriya Announces Gene Therapy Program for Thyroid Eye Disease
December 20, 2023
Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference
: Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference
September 27, 2023
Kriya Announces Exclusive License and Collaboration Agreement with Everads to Advance Gene Therapies for Prevalent Diseases in Ophthalmology Including Geographic Atrophy
: Kriya Announces Exclusive License and Collaboration Agreement with Everads to Advance Gene Therapies for Prevalent Diseases in Ophthalmology Including Geographic Atrophy
1
2
3
Load More